Êtes-vous un étudiant de l'EPFL à la recherche d'un projet de semestre?
Travaillez avec nous sur des projets en science des données et en visualisation, et déployez votre projet sous forme d'application sur GraphSearch.
Concept
Roxana Moslehi
Résumé
Roxana Moslehi is an Iranian-born genetic epidemiologist.
Most of her research is dedicated to the study of cancer and cancer precursors. Born in Iran and raised in Iran and Canada, she is currently an associate professor in Epidemiology and Biostatistics at the University at Albany, State University of New York (SUNY), where she has been teaching multiple courses, including those she developed in genetic and molecular epidemiology. Through her research, she has contributed to understanding hereditary causes of diseases and the influence of gene-environment interactions on the risk of developing disease.
Roxana received her B.Sc. with honors, M.Sc., and Ph.D. degrees from the University of British Columbia (UBC) in Vancouver, Canada, following her Ph.D. under the mentorship of Drs. J.M. Friedman and Steven Narod completed a postdoctoral fellowship at the National Institutes of Health (NIH), Division of Cancer Epidemiology and Genetics (DCEG), under the supervision of Mitchell Gail. While a postdoctoral fellow at the NIH, she received an adjunct assistant professor position at George Washington University (GWU), where she co-taught a course entitled "controversies in cancer epidemiology".
The overarching theme of Roxana Moslehi's research has been identifying and characterizing cancer susceptibility genes. Working with Drs. Steven Narod and J.M. Friedman, her study was among the first to estimate the penetrance of BRCA1 and BRCA2 mutations for breast, ovarian and other cancers in a study of Jewish women with ovarian cancer. Roxana expanded her studies of breast and ovarian cancer to other populations, including those in the Middle East, some understudied at the time. For example, through collaboration with physicians in Iran, Moslehi conducted studies on hereditary breast and ovarian cancer families, which led to the discovery of a novel BRCA1 mutation in the Iranian population.
Source officielle
À propos de ce résultat
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.